FORENSIC TEST FOR HUMAN SALIVA

• US 20070092977A1
• Filed: 10/16/2006
• Published: 04/26/2007
• Est. Priority Date: 10/14/2005
• Status: Abandoned Application

• Current Assignee: Independent Forensics LLC
• Original Assignee: Independent Forensics LLC
• Inventors: Reich, Karl
• Application Number:
  US11/549,951
• Publication Number:
  US 20070092977A1
• Time in Patent Office: Days
• US Class Current: 436/514
• CPC Class Codes: G01N 2333/924 acting on glycosyl compounds (3.2)
• CPC Class Codes: G01N 33/54388 based on lateral flow
• CPC Class Codes: G01N 33/558 using diffusion or migration of antigen or antibody immunochromatographic test strips G01N33/54387
• CPC Class Codes: G01N 33/573 for enzymes or isoenzymes

Abstract

Lateral flow immunochromatographic strip tests for the detection of human saliva, method of detecting human saliva, and methods of manufacturing ICS tests for the detection of human saliva are described.

Claims

1. A device for detecting human saliva, comprising:

a) a wettable material,

b) a sample comprising a first human salivary amylase (hAMY1A) antibody, where said first antibody is labeled for detection, and

c) a second hAMYlA antibody immobilized to said wettable material at a single location,

wherein the first antibody and the second antibody can simultaneously bind to human salivary amylase, but do not bind pancreatic amylase or non-human salivary amylase.

2. The device of claim 1, further comprising an immobilized control antibody adjacent said second hAMY1A antibody wherein said control antibody binds detection antibody in the presence or absence of hAMY1A.

3. The device of claim 1, wherein said wettable material is a lateral flow immunochromatographic strip (ICS) test comprising:

a) a first pad comprising the first hAMY1A antibody labeled for detection;

) a membrane comprising the second hAMY1A antibody immobilized in a test line, and

c) an second pad, wherein said membrane (b) connects said first pad (a) to said second pad.

4. The ICS test of claim 3, further comprising a control antibody immobilized in a control line adjacent said test line on membrane (b) wherein said control antibody binds detection antibody in the presence or absence of hAMY1A.

5. The ICS test of claim 3, wherein said first antibody and said second antibody are combinations selected from the group consisting of polyclonal antibodies, monoclonal antibodies, recombinant antibodies, AMY1, AMY2, and AMY16C.

6. The ICS test of claim 3, wherein said first antibody is labeled with colloidal gold, streptavidin, biotin, microspheres, latex beads, peroxidase, horse radish peroxidase (HRP), streptavidin-labeled HRP, phosphatase, alkaline phosphatase (AP), chromogenic labels, fluorescent labels, phosphorescent labels, or chemiluminescent labels.

7. The ICS test of claim 3, wherein said first antibody and second antibody are selected from the group consisting of AMY1 immobilization antibody and AMY2 detection antibody, AMY1 immobilization antibody and AMY16C detection antibody, AMY2 immobilization antibody and AMY1 detection antibody, AMY2 immobilization antibody and AMY16C detection antibody, AMY16C immobilization antibody and AMY1 detection antibody, AMY16C immobilization antibody and AMY2 detection antibody.

8. The ICS test of claim 3, wherein one or more ICS test is assembled in a cassette.

9. The ICS test of claim 3, wherein one or more ICS test is contained in a kit optionally comprising sample swabs, swab wetting solution, sample tubes, sample tube holder, scissors, sample extraction buffer, sample running buffer, transfer pipet, completed ICS test documentation envelope, syringes, immunochromatographic solutions, additional detection antibodies, secondary enzyme assay reagents, and instructions.

10. A method for detecting the presence of human saliva comprising:

a) swabbing a surface suspected of containing saliva with a swab;

b) resuspending the contents of the swab (a) in buffer;

c) applying buffer (b) to a device for detecting human saliva comprising;

i) a first human salivary amylase (hAMY1A) antibody labeled for detection, and

ii) a second hAMY1A antibody immobilized to a wettable material at a single separate location,

wherein the first antibody and the second antibody can simultaneously bind to human salivary amylase, but do not bind pancreatic amylase or non-human salivary amylase; and

d) detecting the presence or absence of concentrated detection antibodies at the second immobilized antibody wherein the presence of a test line confirms the presence of human saliva.

11. The method of claim 10, wherein said first antibody and second antibody are combinations selected from the group consisting of polyclonal antibodies, monoclonal antibodies, recombinant antibodies, AMY1, AMY2, and AMY16C.

12. The method of claim 10, wherein said first antibody is labeled with colloidal gold, streptavidin, biotin, microspheres, latex beads, peroxidase, streptavidin-labeled horse radish peroxidase (HRP), phosphatase, alkaline phosphatase (AP), chromogenic labels, fluorescent labels, phosphorescent labels, or chemiluminescent labels.

13. The method of claim 10, wherein said first antibody and second antibody are selected from the group consisting of AMY1 immobilization antibody and AMY2 detection antibody, AMY1 immobilization antibody and AMY16C detection antibody, AMY2 immobilization antibody and AMY1 detection antibody, AMY2 immobilization antibody and AMY16C detection antibody, AMY16C immobilization antibody and AMY1 detection antibody, AMY16C immobilization antibody and AMY2 detection antibody.

14. The method of claim 10, wherein said device (c) is a immunochromatographic strip (ICS) test comprising:

i) a first pad comprising the first detection antibody that binds hAMYlA;

ii) a wettable material comprising the second immobilized hAMYlA antibody in a test line, and

iii) a second pad, wherein said wettable material (ii) connects said first pad (i) to said absorbent pad.

15. The method of claim 13, further comprising a comparison of the sample ICS test to one or more ICS tests comprising known concentrations of hAMY1A.

16. The method of claim 13, wherein one or more test strips comprise 0 ng/ml to 100 ng/ml of hAMY1A or concentrations there between.

17. A method of manufacturing one or more human salivary immunochromatographic strip (ICS) tests comprising:

a) placing a backing on one surface;

b) adhering to the backing;

i) a first pad comprising a first human salivary amylase (hAMY1A) antibody labeled for detection,

ii) a second pad opposite the first pad, and

iii) a membrane comprising a second hAMY1A antibody immobilized in a test line wherein said chromatographic membrane contacts both first and second pad, wherein the first antibody and the second antibody can simultaneously bind to human salivary amylase, but do not bind pancreatic amylase or non-human salivary amylase;

c) laminating said components to said backing creating an assembled card; and

d) cutting said assembled card into longitudinal strips to create one or more ICS test strips.

18. The method of claim 17, wherein said first pad is placed atop or adjacent to a third sample pad.

19. The method of claim 17, wherein said first antibody and second antibody are combinations selected from the group consisting of polyclonal antibodies, monoclonal antibodies, recombinant antibodies, AMY1, AMY2, and AMY16C.

20. The method of claim 17, wherein said first antibody is labeled with colloidal gold, streptavidin, biotin, microspheres, latex beads, peroxidase, horse radish peroxidase (HRP), streptavidin-labeled HRP, phosphatase, alkaline phosphatase (AP), chromogenic labels, fluorescent labels, phosphorescent labels, or chemiluminescent labels.

21. The method of claim 17, wherein said first antibody and second antibody are selected from the group consisting of AMY1immobilization antibody and AMY2 detection antibody, AMY1 immobilization antibody and AMY16C detection antibody, AMY2 immobilization antibody and AMY1 detection antibody, AMY2 immobilization antibody and AMY16C detection antibody, AMY16C immobilization antibody and AMY1 detection antibody, AMY16C immobilization antibody and AMY2 detection antibody.

22. The method of claim 17, wherein one or more ICS test is assembled in a cassette.

23. The method of claim 17, wherein one or more ICS test is provided in a kit optionally comprising sample swabs, swab wetting solution, sample tubes, sample tube holder, scissors, sample extraction buffer, sample running buffer, transfer pipet, completed ICS test documentation envelope, syringes, immunochromatographic solutions, additional detection antibodies, secondary enzyme assay reagents, and instructions.